Akihiro Sato
Juntendo University(JP)Instituto Universitario de La Paz(CO)University of Kara(TG)SoftBank Group (Japan)(JP)Benesse Educational Research and Development Institute(JP)National Cancer Center Hospital East(JP)National Institute of Advanced Industrial Science and Technology(JP)Mejiro University(JP)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Gastric Cancer Management and Outcomes, High Temperature Alloys and Creep, High-Temperature Coating Behaviors
Most-Cited Works
- → Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)(2020)899 cited
- → Malignant Astrocytic Tumors: Clinical Importance of Apparent Diffusion Coefficient in Prediction of Grade and Prognosis(2006)374 cited
- → Non-equilibrium steady states in supramolecular polymerization(2017)328 cited
- → Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial(2016)293 cited
- → Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial(2020)265 cited
- → Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial